JOHN MILLS: Open Payments
NPI 1982260402 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 14 payments from 5 companies in 2025. Trend: 2023 $857 · 2024 $568 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $147 |
| Gilead Sciences, Inc. | 4 | $103 |
| Janssen Biotech, Inc. | 3 | $59 |
| Madrigal Pharmaceuticals | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
Products named: LINZESS, TREMFYA, REZDIFFRA, ENTYVIO, CREON.
Industry payments across CA — which companies pay providers there.
